Fundz

Tolerance Bio reported raising $15.1 Million in an initial SEC Form D filing

PRIVATEJun 18, 2026

Amount Raised

$15.1 Million

$15.1 Million sold, per SEC Form D (first sale Jun 3, 2026)

Round Type

Venture

PhiladelphiaBiotechnologyHealth CareTherapeutics

Quick answer

Tolerance Bio raised $15.1 Million in a funding round, dated June 3, 2026. Tolerance Bio is based in Philadelphia, Pennsylvania, United States.

How much did Tolerance Bio raise?
Tolerance Bio raised $15.1 Million in a funding round on June 3, 2026.
What does Tolerance Bio do?
Tolerance Bio, Inc., is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases.
Where is Tolerance Bio based and how big is it?
Tolerance Bio is based in Philadelphia, Pennsylvania, United States.
Who are the decision-makers at Tolerance Bio?
Fundz holds 1 contact at Tolerance Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Tolerance Bio that raised within 45 days of this round, from Fundz verified event records.

  • ME Therapeutics Holdings raised $457K (Post-IPO Equity) on July 17, 2026.
  • Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
  • Georgiamune raised $93M on July 16, 2026.
  • Crescent Biopharma raised $8.1M (Post-IPO Equity) on July 15, 2026.
  • AdvanCell raised $315M (Series D) on July 15, 2026.
  • Draig Therapeutics raised $65M (Series B) on July 14, 2026.

Who to call at Tolerance Bio, and when

A new round usually means Tolerance Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tolerance Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tolerance Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tolerance Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tolerance Bio

Location

Philadelphia, Pennsylvania, United States

About

Tolerance Bio, Inc., is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tolerance Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Tolerance Bio's next move

See what Strategic adds

Tolerance Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.